Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia

Max J. Gordon, Philipp W. Raess, Kathleen Young, Stephen E.F. Spurgeon, Alexey V. Danilov

Research output: Contribution to journalLetterpeer-review

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)501-503
Number of pages3
JournalBritish Journal of Haematology
Issue number3
StatePublished - Nov 2017


  • cytogenetics
  • ibrutinib
  • prolymphocytic leukaemia

ASJC Scopus subject areas

  • Hematology

Cite this